Safety of azithromycin in pediatric infectious diseases: a clinical systematic review and meta-analysis.

ABSTRACT:

Background

Azithromycin is a second-generation macrolide antibiotic which can be used in the treatment of diseases caused by sensitive bacterial infections. This article aimed to investigate the safety of azithromycin in the treatment of infectious diseases in children by meta-analysis.

Methods

PubMed, Embase, and Cochrane were selected as the search database platforms. Randomized controlled trials (RCTs) published after 2010 were searched using the following keywords: "azithromycin", "children", "adverse event", "intravenous event", and "oral". Included studies were all clinical trials of azithromycin in the treatment of pediatric diseases. After inclusion/exclusion criteria screening and bias risk assessment, data were extracted from the included studies. RevMan 5.3.5 soft

SUBMITTER: Li D 

PROVIDER: S-EPMC8578745 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature